Exclusive

Publication

Byline

Novartis malaria treatment Coartem(R) Baby receives WHO prequalification

Singapore, April 26 -- Novartis has announced that the World Health Organization (WHO) has prequalified Coartem(R) (artemether-lumefantrine) Baby, the first and only antimalarial developed specificall... Read More


Singapore's Esco Lifesciences Group announces acquisition of Allwin Medical

Singapore, April 24 -- Singapore-based Esco Lifesciences Group has announced the acquisition of Allwin Medical Devices, Inc., a leading manufacturer of assisted reproductive technology (ART)/ in vitro... Read More


India's Blockchain for Impact inks MoU with Korea's Unicorn Incubator to support healthcare innovation

Singapore, April 24 -- At the India-Korea Business Forum, held recently in New Delhi, Blockchain for Impact (BFI) signed a Memorandum of Understanding (MoU) with Unicorn Incubator, a member of the Fed... Read More


Taiwan unveils breakthrough targeted exosome platform for non-invasive spinal cord injury repair

Singapore, April 24 -- Taiwan-based China Medical University Hospital (CMUH), in collaboration with Ever Supreme International Biotechnology and Shine Out Bio Technology, has unveiled a targeted gene-... Read More


AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US

Singapore, April 24 -- AbbVie has announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina in the US. The state-of-the-art campus will... Read More


CEPI and Pasteur Network partner to advance regional vaccine R&D

Singapore, April 24 -- Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Pasteur Network (PN), in Paris, have signed a Memorandum of Understanding (MoU) to expand collaborati... Read More


Singapore and Japan deepen collaboration to enhance access to health products

Singapore, April 23 -- Singapore's Health Sciences Authority (HSA) and Japan's Ministry of Health, Labour and Welfare (MHLW) have signed a Memorandum of Cooperation (MoC) to enhance bilateral cooperat... Read More


Merck Launches Bio Based Solvent Portfolio For High Performance Liquid Chromatography

Singapore, April 23 -- Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography Merck, a leading science and technology company, announced the launch of the first b... Read More


Hong Kong develops AI pathology system for accurate multi-cancer diagnosis

Singapore, April 23 -- A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology analysis system, named&#... Read More


Australia approves MINJUVI(R) (tafasitamab) for treatment of relapsed or refractory follicular lymphoma

Singapore, April 23 -- Biopharmaceutical company Specialised Therapeutics (ST), based in Singapore, has announced that Minjuvi(R) (tafasitamab), in combination with rituximab and lenalidomide, ha... Read More